^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

estradiol

Company:
Teva
Drug class:
Estrogen receptor agonist
over4years
[VIRTUAL] A Case of Pituitary Hyperplasia Secondary to Uncontrolled Primary Hypothyroidism (ENDO-I 2020)
Her menstrual cycles were regular but this was only after she was placed on norelgestromin/ ethinyl estradiol transdermal patch. Pituitary MRI showed pituitary hyperplasia that has decreased compared to previous MRI, now measuring around 1 cm at the largest dimension without contact with the optic chiasm and the Infundibulum was at midline. Galactorrhea and headaches resolved and fatigue significantly improved.
Clinical
|
IGF1 (Insulin-like growth factor 1)
|
estradiol
almost5years
A Case of Pituitary Hyperplasia Secondary to Uncontrolled Primary Hypothyroidism (ENDO 2020)
Her menstrual cycles were regular but this was only after she was placed on norelgestromin/ ethinyl estradiol transdermal patch. Pituitary MRI showed pituitary hyperplasia that has decreased compared to previous MRI, now measuring around 1 cm at the largest dimension without contact with the optic chiasm and the Infundibulum was at midline. Galactorrhea and headaches resolved and fatigue significantly improved.
Clinical
|
IGF1 (Insulin-like growth factor 1)
|
estradiol